[The following is a paid advertisement.]

Nearly half of U.S. states—both red and blue—have passed laws protecting the 340B program in response to drugmakers restricting access to discounted drugs to hospitals and Federally Qualified Health Centers (FQHCs) serving low-income communities. The courts have overwhelmingly ruled that state laws can prevent pharmaceutical manufacturers from limiting the use of 340B contract pharmacies.

The Illinois Senate unanimously passed 340B legislation last spring. Now it’s up to the Illinois House to vote for House Bill 2371 SA 2, modeled after legislation passed in more than 20 other states. These laws reverse 340B restrictions that are harming patients and the nonprofit, safety net provider organizations caring for them. These providers utilize drug-cost savings to pass on drug discounts to patients and invest in new services, clinics, and hiring of healthcare providers.

HB 2371 SA 2 does NOT require a state appropriation or taxpayer funding. It asks House members to restore this critical lifeline as Illinois hospitals stand to lose up to $57 billion in federal Medicaid funding over 10 years—and patients lose Medicaid coverage.

Get the 304B bill across the finish line this legislative session: Vote YES on HB 2371 SA 2. Learn more.